Your browser doesn't support javascript.
loading
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.
Birtas Atesoglu, Elif; Gulbas, Zafer; Uzay, Ant; Ozcan, Muhit; Ozkalemkas, Fahir; Dal, Mehmet Sinan; Kalyon, Hakan; Akay, Olga Meltem; Deveci, Burak; Bekoz, Huseyin; Sevindik, Omur Gokmen; Toptas, Tayfur; Yilmaz, Fergun; Koyun, Derya; Alkis, Nihan; Alacacioglu, Inci; Sonmez, Mehmet; Yavasoglu, Irfan; Tombak, Anil; Mehtap, Ozgur; Kurnaz, Fatih; Yuce, Orhan Kemal; Karakus, Volkan; Turgut, Mehmet; Kurekci, Derya Deniz; Ayer, Mesut; Keklik, Muzaffer; Buyuktas, Deram; Ozbalak, Murat; Ferhanoglu, Burhan.
Afiliación
  • Birtas Atesoglu E; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey.
  • Gulbas Z; Division of Hematology, Anadolu Medical Center, Kocaeli, Turkey.
  • Uzay A; Division of Hematology, Acibadem Atakent Hospital, Istanbul, Turkey.
  • Ozcan M; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey.
  • Ozkalemkas F; Department of Internal Medicine, Division of Hematology, Uludag University Medical Faculty, Bursa, Turkey.
  • Dal MS; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Hospital, Ankara, Turkey.
  • Kalyon H; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey.
  • Akay OM; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey.
  • Deveci B; Division of Hematology, Medstar Hospital, Antalya, Turkey.
  • Bekoz H; Department of Internal Medicine, Division of Hematology, Medipol University Medical Faculty, Istanbul, Turkey.
  • Sevindik OG; Department of Internal Medicine, Division of Hematology, Medipol University Medical Faculty, Istanbul, Turkey.
  • Toptas T; Department of Internal Medicine, Division of Hematology, Marmara University Medical Faculty, Istanbul, Turkey.
  • Yilmaz F; Department of Internal Medicine, Division of Hematology, Marmara University Medical Faculty, Istanbul, Turkey.
  • Koyun D; Department of Internal Medicine, Division of Hematology, Ankara University Medical Faculty, Ankara, Turkey.
  • Alkis N; Division of Hematology, Bursa City Hospital, Bursa, Turkey.
  • Alacacioglu I; Department of Internal Medicine, Division of Hematology, Dokuz Eylul University Medical Faculty, Izmir, Turkey.
  • Sonmez M; Department of Internal Medicine, Division of Hematology, Karadeniz Technical University Medical Faculty, Trabzon, Turkey.
  • Yavasoglu I; Department of Internal Medicine, Division of Hematology, Adnan Menderes University Medical Faculty, Aydin, Turkey.
  • Tombak A; Department of Internal Medicine, Division of Hematology, Mersin University Medical Faculty, Mersin, Turkey.
  • Mehtap O; Department of Internal Medicine, Division of Hematology, Kocaeli University Medical Faculty, Kocaeli, Turkey.
  • Kurnaz F; Division of Hematology, Kocaeli Medicalpark Hospital, Kocaeli, Turkey.
  • Yuce OK; Department of Internal Medicine, Division of Hematology, Akdeniz University Medical Faculty, Antalya, Turkey.
  • Karakus V; Division of Hematology, Antalya Research and Training Hospital, Antalya, Turkey.
  • Turgut M; Department of Internal Medicine, Division of Hematology, Ondokuzmayis University Medical Faculty, Samsun, Turkey.
  • Kurekci DD; Department of Internal Medicine, Division of Hematology, Ondokuzmayis University Medical Faculty, Samsun, Turkey.
  • Ayer M; Division of Hematology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey.
  • Keklik M; Department of Internal Medicine, Division of Hematology, Erciyes University Medical Faculty, Kayseri, Turkey.
  • Buyuktas D; Division of Hematology, V.K.V. American Hospital, Istanbul, Turkey.
  • Ozbalak M; Division of Hematology, Basaksehir Cam ve Sakura City Hospital, Istanbul, Turkey.
  • Ferhanoglu B; Department of Internal Medicine, Division of Hematology, Koc University School of Medicine, Istanbul, Turkey.
Hematol Oncol ; 41(4): 663-673, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37211991

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: Hematol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Turquía